TMThomas Magauer

Thomas Magauer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Thomas Magauer has a total of 164 co-authors. Here are the top co-authors by number of shared publications:

  • Klaus Wurst

    Department of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria

    24 shared publications
  • Immanuel Plangger

    Department of Organic Chemistry and Center for Molecular Biosciences (CMBI) University of Innsbruck Innsbruck Austria

    10 shared publications
  • Klaus Speck

    Department of Organic Chemistry and Center for Molecular Biosciences (CMBI), University of Innsbruck

    9 shared publications
  • Cedric L. Hugelshofer

    Department of Discovery Chemistry, Merck & Co., Inc., South San Francisco, California 94080, United States

    8 shared publications
  • Christian Steinborn

    Department of Organic Chemistry and Center for Molecular Biosciences (CMBI) University of Innsbruck Innsbruck Austria

    8 shared publications
  • Raphael Wildermuth

    Department of Organic Chemistry and Center for Molecular Biosciences (CMBI) University of Innsbruck Innsbruck Austria

    7 shared publications

Latest Publications

  • Synthetic Strategies for Oxygenated Cyclohexanoid Frameworks

    by Elias Schmidhammer, Thomas Magauer

    Highly oxygenated cyclohexanoid frameworks are key structural features in many natural products and remain challenging synthetic targets. Herein, we report investigations into two strategies for their preparation. A high-pressure Diels–Alder reaction enabled the construction of a temporary decalin scaffold, exploiting the stereochemistry established through ring formation, but was ultimately limited by unsuccessful alkene transposition. A semi-pinacol rearrangement strategy sought to introduce stereochemical information through functionalization of a monocyclic precursor but was limited by competing halide-mediated epoxide opening. Together, these studies illustrate two distinct strategies for stereochemical control, bicyclic ring formation and monocyclic functionalization, in the synthesis of oxygenated cyclohexanoid frameworks and highlight the challenges associated with their implementation.

  • Open Access

    Reorganization of Innate Immune Cell Lipid Profiles by Bioinspired Meroterpenoids to Limit Inflammation

    by Lorenz Waltl, David Holubek, Klaus Speck, Raphael Wildermuth, Franz‐Lucas Haut, Stephan Permann, Immanuel Plangger, Christian Steinborn, Zhigang Rao, Danilo D'AVino, et al.

    Lipidomics‐guided screening of unexplored natural product chemical space provides access to small molecules that globally reprogram cellular lipid profiles. Here, we show that the meroterpenoid cyclosmenospongine from Spongia sp . reshapes immune cell lipidomes, shifting them from pro‐inflammatory toward anti‐inflammatory and pro‐resolving mediators. Structural variation yielded derivatives that context‐dependently inhibit leukotriene biosynthesis to varying extents while upregulating pro‐resolving lipid mediators, epoxyeicosatrienoic acids, endocannabinoids, sphingosine‐1‐phosphate, and others in resting and activated innate immune cells in vitro, as well as in self‐resolving murine peritonitis and fibrosis in vivo. Mechanistically, meroterpenoids target 5‐lipoxygenase or 5‐lipoxygenase‐activating protein, promote 15‐lipoxygenase‐1 translocation to particulate sites, and inhibit monoacylglycerol lipase. They also redirect arachidonic acid from neutral lipids to specific phospholipids while increasing free arachidonic acid levels. Furthermore, meroterpenoids reprogram immune cell lipid metabolism by reducing neutral lipid, triacylglycerol, and cholesteryl ester levels, a shift that correlates with a lower capacity for leukotriene biosynthesis and is phenocopied by inhibiting sterol‐O‐acyltransferase, which catalyzes cholesterol esterification for storage, and diacylglycerol acyltransferase‐1/2, which catalyze the final step in triacylglycerol biosynthesis. In conclusion, specific meroterpenoids exert anti‐inflammatory effects by rewiring lipid mediator biosynthesis through structure‐controlled switches in lipid mediator classes, and an unexpected link between lipogenesis and inflammation.

  • Open Access

    Advances in the total synthesis of iridals

    by Elias Schmidhammer, Thomas Magauer

    Iridals are a family of natural products predominantly found in species of the genus Iris . Biosynthetically, they originate from the triterpenoid squalene. Numerous members of this family have been studied for their bioactivity, exhibiting anticancer, antiplasmodial, antifungal, and piscicidal properties. Despite their bioactivities and discovery in 1982 and over 100 members now known, only a single iridal has been synthesized, with other efforts confined to partial syntheses or biosynthetic intermediates. This review presents the synthetic advancements in the total synthesis of iridal family members, including that of the parent compound iridal.

  • Open Access

    Nano bio-responsive systems avoiding methicillin resistant Staphylococcus aureus colonization on an implant surface

    by Mariana Blanco Massani, Anna Grobelny, Michael Badart, Sergio Diaz-Coello, Thomas Magauer, Susanne Meile, Annabelle Knoll, Lana Molnar, Martin J. Loessner, Mathias Schmelcher, et al.


  • Open Access

    One-pot synthesis of ethylmaltol from maltol

    by Immanuel Plangger, Marcel Jenny, Gregor Plangger, Thomas Magauer

    A novel route to the flavor enhancer ethylmaltol, a synthetic 4-pyrone, from naturally abundant maltol is disclosed. Two strategies were explored for the required C1 homologation. The most direct approach, C–C bond formation via methylation of a dianionic intermediate, proved unsuitable due to competing overalkylation and the necessity of sub-zero temperatures. In contrast, a transient protecting group approach enabled selective methylation under mild conditions. This culminated in a scalable, operationally simple one-pot synthesis of ethylmaltol from a renewable precursor.

  • Open Access

    Unified Total Synthesis of Phrymarolin and Haedoxan Natural Products

    by Jan Paciorek, Antoine D. F. Guy, Alexander Sudau, David M. Barber, Thomas Magauer

    We disclose a unified synthetic route to the furofuran lignans phrymarolin I and II as well as the insecticidal natural products haedoxan A and D. The furofuran core was constructed using a formal [3 + 2] cycloaddition between an α-silyloxy aldehyde and a styrene, followed by a samarium(II) iodide promoted-cyclization of a β-formyloxy ketone. While this sequence enabled the synthesis of phrymarolin I and II in eight steps, attempts to unmask the ortho-quinone necessary for a bioinspired formal [4 + 2] cycloaddition were unsuccessful, initially preventing access to the haedoxans. Revising the choice of the arene substitution pattern enabled the formation of the requisite ortho-quinone followed by a bioinspired cyclization to the 1,4-benzodioxane motif of the haedoxan framework. Finally, late-stage diversification at the acetal position enabled completion of the synthesis of haedoxan A and D and their analogues in 13 steps. The synthetic route facilitated insecticidal screening of fully synthetic analogues modified at the O-aryl residue.

  • Open Access

    Unified Total Synthesis of Phrymarolin And Haedoxan Natural Products

    by Jan Paciorek, Antoine Guy, Alexander Sudau, David Barber, Thomas Magauer

    We disclose a unified synthetic route to the furofuran lignans phrymarolin I and II as well as the insecticidal natural products haedoxan A and D. The furofuran core was constructed using a formal [3+2] cycloaddition between an α-silyloxy aldehyde and a styrene, followed by a samarium(II) iodide promoted-cyclization of a β-formyloxy ketone. While this sequence enabled the synthesis of phrymarolin I and II in eight steps, attempts to unmask the ortho-quinone necessary for a bioinspired formal [4+2] cycloaddition were unsuccessful, initially preventing access to the haedoxans. Revising the choice of the arene substitution pattern enabled the formation of the requisite ortho-quinone followed by a bioinspired cyclization to the 1,4-benzodioxane motif of the haedoxan framework. Finally, late-stage diversification at the acetal position enabled completion of the synthesis of haedoxan A and D in thirteen steps.

  • Open Access

    Evolution of a Strategy for the Total Synthesis of the Ganoderma Meroterpenoid Ganoapplanin

    by Nicolas Müller, Ondřej Kováč, Alexander Rode, Daniel Atzl, Clemens Dietrich, Ana V. Serna, Sebastian Schaar, Antonio Paparesta, Julian Lichtenegger, Thomas Magauer

    Herein, a detailed account of the efforts leading to the recently published synthesis of the Ganoderma meroterpenoid ganoapplanin, a natural product identified as an inhibitor of T‐type voltage‐gated calcium channels, is provided. Ganoapplanin, which was isolated as a racemate from the fungus Ganoderma applanatum in 2016, features a complex structure, including a characteristic spiro bisacetal structure, a highly functionalized tetra‐ortho‐substituted biaryl motif, and a propellane‐like dioxatricyclo[4.3.3.0]dodecane scaffold. While the southern terpenoid fragment is available via a diastereoselective titanium‐mediated iodolactonization, considerable efforts are required to fuse this fragment with various aromatic fragments. The breakthrough was achieved by a highly efficient two‐component coupling strategy that simultaneously fuses the fragments and establishes the crucial biaryl bond. This transformation involves an intramolecular 6‐exo‐trig radical addition of a quinone monoacetal, followed by an intermolecular aldol addition. Finally, strategic late‐stage oxidations enabled the formation of the characteristic spiro bisacetal motif and the completion of the synthesis of ganoapplanin.


  • Open Access

    Natural Product Synthesis Enabled by Radical-Polar Crossover Reactions

    by Nicolas Müller, Thomas Magauer, Ondřej Kováč

    Radical-polar crossover (RPC) chemistry is an emerging field characterized by transformations that involve the coexistence of both radical and ionic species. Since the reactivities of radical and ionic intermediates are orthogonal, applying these two mechanisms in sequence provides significant advantages in the construction of complex molecular architectures. The concept of the RPC approach has become increasingly important in the total synthesis of natural products. This Synopsis presents several examples to showcase recent advancements in this area, including our research on the synthesis of Ganoderma meroterpenoids. In these selected cases, RPC reactions enhance the building of structural complexity and improve overall synthetic efficiency that cannot be achieved by standard synthetic methods.


  • Open Access

    Non-enzymatic methylcyclization of alkenes

    by Immanuel Plangger, Elias Schmidhammer, Sebastian Schaar, Klaus Wurst, Maren Podewitz, Thomas Magauer

    Methyltransferases are a broad class of enzymes that catalyse the transfer of methyl groups onto a wide variety of substrates and functionalities. In their most striking variant, bifunctional methyltransferase–cyclases both transfer a methyl group onto alkenes and induce cyclization (methylcyclization). Although recent years have seen substantial advances in the methylation of alkenes, especially hydromethylation, the reactivity demonstrated by bifunctional methyltransferase–cyclases in nature has yet to be developed into a synthetically viable method. Here we report a silver(I)-mediated electrophilic methylcyclization that rivals selectivities found in enzymes while not being limited by their inherent substrate specificity. Our method benefits from the use of commercial reagents, is applicable to a wide range of substrates, including heterocycles, and affords unique structures that are difficult to access via conventional synthetic methods. Furthermore, computational studies have been utilized to unravel the underlying mechanism and ultimately support a stepwise cationic reaction pathway with a rate-limiting methyltransfer.